Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin/Tramadol FDC vs Pregabalin in Acute Neuropathic Pain
NCT05324059Phase 3Completed
- Sponsor
- Laboratorios Silanes
- Start
- Jul 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in neuropathic pain comparing Pregabalin/Tramadol with Pregabalin (2 arms). Primary endpoints: Proportion of subjects with a success rate of >50% in pain reduction at 15 days, Mean change in pain intensity by Visual Analog Scale (VAS) at 15 days and 3 more. Started Jul 2022; status: completed.
02
Drugs
pregabalintramadol
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05324059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324059.